Raf and PI3K are the Molecular Targets for the Anti‐metastatic Effect of Luteolin
- 21 November 2012
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 27 (10) , 1481-1488
Abstract
Metastases are the primary cause of human cancer deaths. Luteolin, a naturally occurring phytochemical, has chemopreventive and/or anticancer properties in several cancer cell lines. However, anti‐metastatic effects of luteolin in vivo and the underlying molecular mechanisms and target(s) remain unknown. Luteolin suppresses matrix metalloproteinase (MMP)‐2 and ‐9 activities and invasion in murine colorectal cancer CT‐26 cells. Western blot and kinase assay data revealed that luteolin inhibited Raf and phosphatidylinositol 3‐kinase (PI3K) activities and subsequently attenuated phosphorylation of MEK and Akt. A pull‐down assay indicated that luteolin non‐competitively bound with ATP to suppress Raf activity and competitively bound with ATP to inhibit PI3K activity. GW5074, a Raf inhibitor, and LY294002, a PI3K inhibitor, inhibited MMP‐2 and ‐9 activities and invasion in CT‐26 cells. An in vivo mouse study showed that oral administration (10 or 50 mg/kg) of luteolin significantly inhibited tumor nodules and tumor volume of lung metastasis induced by intravenous injection of CT‐26 cells. Luteolin also inhibited MMP‐9 expression and activity in CT‐26‐induced mouse lung tissue. These results suggest that luteolin may have considerable potential for development as an anti‐metastatic agent. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
Funding Information
- Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008187)
- Rural Development Administration, Republic of Korea, the National Research Foundation of Korea (NRF) grant funded by the Korea government (No. 2010-0029233)
- World Class University program (Grant R31-2008-00-1-56-0)
This publication has 31 references indexed in Scilit:
- Silibinin Triggers Apoptosis and Cell‐Cycle Arrest of SGC7901 CellsPhytotherapy Research, 2012
- Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1Cancer Prevention Research, 2011
- PPARα and PPARγ protect against HIV‐1‐induced MMP‐9 overexpression via caveolae‐associated ERK and Akt signalingThe FASEB Journal, 2011
- Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt–GSK-3β–Cyclin D1 pathwayCancer Letters, 2010
- Learning therapeutic lessons from metastasis suppressor proteinsNature Reviews Cancer, 2009
- Raf kinases: Function, regulation and role in human cancerBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K–Akt pathwaysChemico-Biological Interactions, 2006
- Exploiting the PI3K/AKT Pathway for Cancer Drug DiscoveryNature Reviews Drug Discovery, 2005
- Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase IBiochemical Journal, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002